DEFTA Partners

DEFTA Partners

A San Francisco-based venture capital firm that invests in information technology companies

DEFTA Partners is a venture capital firm in San Francisco that focuses on the information technology and healthcare sectors. Founded in 1984 in San Francisco, California, the firm invests in early stage venture, late stage venture, and seed stages. This firm usually invests in series A and series B rounds. The notable investment portfolio of DEFTA Partners includes Cloudfiling, Fortinet, bracNet, Abilitech Medical, Aivick, etc.

As of January 2020, DEFTA Partners has made 56 investments and 25 exits.

Timeline

1984

Founded

Funded Companies

Company
Description
Industry
Website
Location
Orig3n

Orig3n is a biotechnology company developing personalized regenerative medicine treatments based on patient genetic profiles.

Aegle Therapeutics Corporation, a regenerative medicine company isolating extracellular vesicles ("EVs") from allogeneic bone marrow derived mesenchymal stem cells (MSCs) to treat severe dermatological conditions, including burns and epidermolysis bullosa (“EB”).

Immusoft is a biotechnology company developing a platform for the insertion of therapeutic genes into immune cells for the treatment of a variety of genetic diseases.

4 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Arie Kahana

Partner

George Hara

Managing Partner

Kyoko Watanabe

Director

Masa Isono

Principal

Stan Sakai

Partner

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

Actuate Therapeutics

Aegle Therapeutics

BIoEclipse Therapeutics

DiA Imaging Analysis

Immusoft

ORIG3N

Savonix

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.